Hong‐Tai Chang

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial

Cristina Saura, Mafalda Oliveira, Yin‐Hsun Feng et al. · Journal of Clinical Oncology · 2020 · 609 citations · Full text

Medicine, Oncology, Pharmacology +15

Hypoxia Drives Breast Tumor Malignancy through a TET–TNFα–p38–MAPK Signaling Axis

Min-Zu Wu, Su-Feng Chen, Shin Nieh et al. · Cancer Research · 2015 · 149 citations · Full text

Medicine, Cancer Biology, Oncology +17

Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: Results from AVADO

Xavier Pivot, Andreas Schneeweiß, Shailendra Verma et al. · European Journal of Cancer · 2011 · 110 citations

Medicine, Oncology, Pharmacotherapy +9

Extracellular Matrix–receptor Interaction Signaling Genes Associated with Inferior Breast Cancer Survival

Ming-Hsin Yeh, YAU-JIN TZENG, Ting‐Ying Fu et al. · Anticancer Research · 2018 · 67 citations · Full text

Medicine, Cancer Biology, Oncology +17

Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan

Steven Shoei‐Lung Li, H.-M. Tseng, Tsui-Ping Yang et al. · Human Genetics · 1999 · 59 citations

Medicine, Genetics, Molecular Genetics +13